相关实验视频
Updated: May 2, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
最佳血糖水平与感染性休克重症患者的死亡率之间的关联:现实世界的时间序列数据分析
Gulizeba Muhetaer1, Ce Sun2, Qian-Qian Ma1
1Shenzhen Bao'an Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Nursing in critical care
|March 11, 2025
概括
维持时间加权平均血糖 (TWA-BG) 在105-131 mg/dL之间对于感染性休克患者至关重要. 这一目标范围显著降低了重症监护病房的死亡风险.
科学领域:
- 关键护理医学 关键护理医学
- 内分泌学 在内分泌学.
- 在医疗保健中的数据科学.
背景情况:
- 败血症和败血性休克在ICU中构成重大挑战,由于代谢失调,需要精确的血糖管理.
- 高血糖和低血糖都会对败血症患者的结果产生负面影响,强调需要有效的血糖控制.
- 对于败血症休克患者的最佳血糖目标仍然不清楚,这促使需要进一步研究.
研究的目的:
- 为了确定性休克患者的最佳血糖目标.
- 分析时间序列血糖数据,以确定理想的血糖范围,以改善患者的治疗结果.
主要方法:
- 使用MIMIC-IV数据库 (2008-2019) 进行的回顾性观察研究.
- 包括被诊断患有败血性休克的ICU患者.
- 时间序列血糖数据使用斯坦曼插值,时间加权平均血糖 (TWA-BG) 计算和Cox回归与受限制的立方线分析.
- 进行敏感性和子组分析以确保稳定性.
主要成果:
- 分析了来自34677个确诊病例中的11,375名败血症休克患者.
- 确定最佳TWA-BG范围为105-131 mg/dL,与最低的28天死亡风险相关.
- 目标范围内的患者与范围以外的患者相比,死亡率明显较低.
- 敏感性分析证实了各个子组和模型的研究结果的稳定性.
结论:
- 维持TWA-BG水平在105-131 mg/dL之间与28天,ICU和在感染性休克患者的住院死亡率降低有关.
- 这些发现为ICU护理干预和血糖控制策略提供了基于证据的指导.
- 该研究提出了一个精确的TWA-BG范围,可以为重症监护中的血糖管理设定新的基准.
相关概念视频
Errors occurring during blood pressure monitoring
580
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
580
Hypoglycemia and Glucagon
148
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
148
Comparing the Survival Analysis of Two or More Groups
115
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
115

